Wenzhao Zhong

27PUBLICATIONS
94CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 02, 2025
Lysosome-mediated aggregation of galactose-deficient IgA1 with transferrin receptor 1 links to IgA nephropathy.

Meijun Si, Jingpeng Fu, Mengting Fang

|Jun 19, 2025
Impaired natural killer cell maturation in lung adenocarcinoma driven by FABP4 and SPON2 downregulation through disrupted lipid metabolism.

Hongxia Tian, Kezhen Li, Jing Chen

|Jan 24, 2025
Follow-up Analysis Enhances Understanding of Molecular Residual Disease in Localized Non-Small Cell Lung Cancer.

Jia-Tao Zhang, Si-Yang Liu, Xuan Gao

|Aug 02, 2024
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China.

Chunwei Xu, Zhanhong Chen, Yuanli Xia

|Jan 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Gen Lin, Zhijie Wang, Qian Chu

|Dec 06, 2023
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.

Si-Yang Liu, Song Dong, Xue-Ning Yang

Pageof 5

Frequent Collaborators

8 joint publications

Wenxian Wang

7 joint publications

Chengzhi Zhou

7 joint publications

Chunwei Xu

7 joint publications

Yong Song